Selected Quarterly Financial Data (Unaudited) (Notes)

12 Months Ended

Dec. 31, 2012

Selected Quarterly Financial Information [Abstract]

Selected Quarterly Financial Data (Unaudited)

SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)

	2012								2011
	Q1		Q2		Q3		Q4(1)		Q1			Q2		Q3(2)		Q4(3)
	(In thousands, except per share amounts)
Net sales	$	33,269	$	35,035	$	35,230	$	36,751	$	30,422		$	32,214	$	32,127	$	32,524
Gross profit	24,301		25,515		25,606		26,936		21,495			22,901		23,444		23,724
Net income (loss)	12		636		905		673		(154		)	584		109		355
Net income (loss) per share (4):
Basic	$	0.00	$	0.02	$	0.03	$	0.02	$	(0.00	)	$	0.02	$	0.00	$	0.01
Diluted	0.00		0.02		0.03		0.02		(0.00		)	0.02		0.00		0.01

(1) During the fourth quarter of 2012, the Company incurred $0.3 million in legal and other costs related the to acquisition of certain products from Upstream (for additional discussion, see Note 15).

(2) During the third quarter of 2011, the Company recorded a $0.8 million charge, which amount included $0.2 million of interest through September 2011, related to a September 2011 ruling by the Dutch Court of Appeals in favor of Cardiomedica (for additional discussion, see Note 14).

(3) During the fourth quarter of 2011, the Company recorded the following special charges or credits not related to the Company’s regular, ongoing business: (i) a license agreement termination charge of $1.8 million (see Note 13) and (ii) a credit of $0.4 million representing a reduction in the Company’s estimated liability related to indemnification agreements with three former employees.

(4) The sum of the quarterly net income per share amounts may not total to each full year amount because these computations are made independently for each quarter and for the full year, and take into account the weighted average number of common stock equivalent shares outstanding for each period.